Diagnostic antibodies and antigens for gastric disease testing: pepsinogen I (PG I), Pepsinogen II (PG II), Gastrin 17 (G17), trefoil factor 1 (TFF1), Gastrin (G100)

Gastric disorders are the most common disease leads to the death. Most death of gastric disease is mostly due the diagnosis at late-stage. The diagnosis of Gastric disease at early-stage is delayed due to the lack symptoms and effective diagnostic technique. The traditional technology, including endoscopic examination and gastroscopic biopsy are invasive to screen large population. Hence, biomarkers such as pepsinogen I, Pepsinogen II, Gastrin 17, trefoil factor 1, Gastrin and so on have been developed to detect the gastric diseases at an early stage for large population to significantly reduce the death caused by gastric cancer. However, the detection of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

pepsinogen I (PG I)

Filters Sort results
Reset Apply
Cat No.
Species
Biomarker
Disease
Cat No.of Antigen
Bioactivity validation of Antigen
Cat No.of Antibodies
Bioactivity validation of Antibodies
Order
Human
pepsinogen I
GMP-h-PG-I-Ag01
pepsinogen I (PG I) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation
GMP-h-PG-I-Ab01;GMP-h-PG-I-Ab02:Anti-Human PG I mouse monoclonal antibody (mAb)
Human pepsinogen I (PG I) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pepsinogen I (PG I) antibodies in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation.

Pepsinogen II (PG II)

Filters Sort results
Reset Apply
Cat No.
Species
Biomarker
Disease
Cat No.of Antigen
Bioactivity validation of Antigen
Cat No.of Antibodies
Bioactivity validation of Antibodies
Order
Human
Pepsinogen II
GMP-h-PG-II-Ag01
Pepsinogen II (PG II) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PG II level test of Gastric disease (pernicious anemia) and related syndrome evaluation
GMP-h-PG-II-Ab01;GMP-h-PG-II-Ab02:Anti-Human PG II mouse monoclonal antibody (mAb)
Human Pepsinogen II (PG II) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Pepsinogen II (PG II) antibodies in PG II level test of Gastric disease (pernicious anemia) and related syndrome evaluation.

Gastrin 17 (G17)

Filters Sort results
Reset Apply
No results found. Clear filters and try again?

trefoil factor 1 (TFF1)

Filters Sort results
Reset Apply
No results found. Clear filters and try again?

Gastrin (G100)

Filters Sort results
Reset Apply
Cat No.
Species
Biomarker
Disease
Cat No.of Antigen
Bioactivity validation of Antigen
Cat No.of Antibodies
Bioactivity validation of Antibodies
Order
Human
Gastrin
GMP-h-G100-Ag01
Gastrin (G100) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in G100 level test of Gastric disease (gastrinoma) and related syndrome evaluation
GMP-h-G100-Ab01;GMP-h-G100-Ab02:Anti-Human G100 mouse monoclonal antibody (mAb)
Human Gastrin (G100) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Gastrin (G100) antibodies in G100 level test of Gastric disease (gastrinoma) and related syndrome evaluation.
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.